Radiation therapy for testicular seminoma: controversies in the management of early-stage disease.
Subdiaphragmatic irradiation remains the standard treatment for patients with stage I and IIA testicular seminoma. Elective mediastinal irradiation is not indicated. In well-selected patients with stage I disease, aggressive surveillance may be a reasonable alternative to elective irradiation. We believe that bipedal lymphangiography is useful in staging, radiation field design, and follow-up. Other controversies in the radiotherapeutic management include the optimal radiation dose and appropriate target volume.
Marks
L B
LB
Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Anscher
M S
MS
Shipley
W U
WU
D004407:Dysgerminoma / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D013736:Testicular Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*